The economic burden of environmental tobacco smoke in the first year of life by Ho, LM et al.
Title The economic burden of environmental tobacco smoke in thefirst year of life
Author(s) Leung, GM; Ho, LM; Lam, TH
Citation Archives Of Disease In Childhood, 2003, v. 88 n. 9, p. 767-771
Issued Date 2003
URL http://hdl.handle.net/10722/43582
Rights Archives of Disease in Childhood. Copyright © B M J PublishingGroup.
doi:10.1136/adc.88.9.767 
 2003;88;767-771 Arch. Dis. Child.
  
G M Leung, L-M Ho and T-H Lam 
  
 smoke in the first year of life
The economic burden of environmental tobacco
 http://adc.bmj.com/cgi/content/full/88/9/767
Updated information and services can be found at: 
 These include:
 References
 http://adc.bmj.com/cgi/content/full/88/9/767#otherarticles
4 online articles that cite this article can be accessed at: 
  
 http://adc.bmj.com/cgi/content/full/88/9/767#BIBL
This article cites 14 articles, 8 of which can be accessed free at: 
Rapid responses
 http://adc.bmj.com/cgi/eletter-submit/88/9/767
You can respond to this article at: 
 service
Email alerting
top right corner of the article 
Receive free email alerts when new articles cite this article - sign up in the box at the
Topic collections
 (619 articles) Infants 
 (386 articles) Health Economics 
 (1086 articles) Smoking 
  
Articles on similar topics can be found in the following collections 
 Notes   
 http://www.bmjjournals.com/cgi/reprintform
To order reprints of this article go to: 
 http://www.bmjjournals.com/subscriptions/
 go to: Archives of Disease in ChildhoodTo subscribe to 
 on 7 November 2006 adc.bmj.comDownloaded from 
ORIGINAL ARTICLE
The economic burden of environmental tobacco smoke in
the first year of life
G M Leung, L-M Ho, T-H Lam
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Arch Dis Child 2003;88:767–771
Aims: To examine the population impact and economic costs associated with environmental tobacco
smoke (ETS) in Chinese infants with non-smoking mothers.
Methods: Prospective, population based birth cohort study in Hong Kong, 1997–98. Main outcome
measures were: doctor consultations and hospitalisations; adjusted odds ratios for higher utilisation by
service type for each of the ETS exposure variables; corresponding population attributable risks (PARs);
and associated extra health care costs.
Results: For the 1997 annual birth cohort, ETS exposure through the mother in utero was positively
associated with higher consultation (adjusted odds ratio (OR) 1.26) and hospitalisation (OR 1.18) due
to any illness. This translated into 7.4% of all inpatient episodes in the first year of life, representing an
additional 1581 hospital attendances that cost over US$2.1 million. The corresponding PAR for
outpatient services was 7.7%, where the majority was due to respiratory or febrile illnesses, account-
ing for $0.44 million in extra costs. Postnatal exposure to ETS at home was linked to higher rates of
hospitalisations for any illness compared with non-exposed infants (OR 1.12), which led to 662 extra
hospitalisations consuming $0.90 million, where the associated PAR was 3.1%.
Conclusions: Assuming that ETS was causally associated with health services use, about 9% of the
total direct medical costs in the first year of life can be attributed to passive smoking. The community,
as well as the private citizen, needs to be made aware of the costs foregone from exposure to tobacco
smoke as well as the potential savings from a smoke-free society.
Estimating the societal impact of environmental tobaccoexposure (ETS) in infants and children, the extent of thatexposure, and the economic costs associated with it are
important in providing the information necessary for evidence
based action to reduce the public health consequences of ETS
on paediatric and perinatal health.1 Specifically, if ETS is esti-
mated to have a large impact on health costs, policymakers are
more likely to invest in intervention programmes to reduce
ETS exposure of infants and young children.
Health impact can be measured using established proce-
dures such as the population attributable risk (PAR) method.
This combines the relative risk of disease in exposed children
with the prevalence of exposure in the population to estimate
the proportion of disease caused by passive smoking. From a
public and preventive health perspective, even if each exposed
individual is only slightly affected in terms of ill health, the
potential avoidable burden of disease in the whole population
can be substantial if the prevalence of exposure is high.2 Such
is the case for tobacco related disease where almost half of the
world’s children are exposed to ETS. In some parts of Asia, for
example Japan, this rate exceeds 60%.3 In addition, estimating
the cost of children’s exposure to tobacco smoke is important
in evaluating tax and fiscal policy, as well as managing the
ever upward public and private health care cost spirals.4
Economic impact studies are also useful from a health services
perspective because they highlight the potential savings if
exposure of infants and children to environmental tobacco
smoke is eliminated or at least minimised.1
While the biological and clinical effects of ETS on infants
and children have been consistently and conclusively
shown,5 6 there are only sparse and contradicting reports in the
literature about whether these effects lead to higher health
services use by exposed subjects. Recently, we confirmed that
exposure to ETS translated into higher services use by exposed
infants during the first 18 months of life in a population based
birth cohort of Hong Kong infants in 1997.7 In the present
study, we report the PARs and costs of the additional service
utilisation associated with ETS exposure in this birth cohort.
Of note, the rate of maternal smoking (4.6%) is very low
compared with other developed economies such as the United
States (31.7%).8 This makes Hong Kong an ideal setting to
study the independent effects of ETS from non-maternal
sources on infants’ health. It is often difficult to completely
disentangle the effects of ETS from smoking by mothers ver-
sus others in communities where the maternal smoking
prevalence is high, because post hoc adjustment is less than
ideal in isolating such effects.
We therefore specifically examined the contribution of ETS
from fathers and other household contacts to extra health care
costs as a result of infants’ morbidity exclusive of maternal
smoking.Our objectives were to study the effects of ETS on the
population attributable risks and direct medical costs in a
birth cohort of local Chinese infants who had non-smoking
mothers.
METHODS
Sources of data
Details of the study methodology have been published
previously.7 We report here a synopsis of the methods. Data for
this paper were drawn from a prospective birth cohort study
conducted at all 47 maternal and child health centres
(MCHCs) of the Hong Kong Government’s Department of
Health in 1997. The vast majority of infants in Hong Kong,
regardless of the family’s ability to pay, visit the MCHCs for
preventive care and immunisations. For the index year, 92% of
all infants born in Hong Kong attended an MCHC at least
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Abbreviations: CI, confidence interval; ETS, environmental tobacco
smoke; MCHC, maternal and child health centre; OR, odds ratio; PAR,
population attributable risk
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once.9 The sampling frame consisted of all infants brought to
an MCHC for their first visit after birth in April and May of
1997. The response rate to our study was 95%, accounting for
88% of all births in the period. There were 8327 mother-infant
pairs in the final cohort. Among other items,mothers provided
information on breast feeding history, household smoking
habits, mode of delivery, and other demographic, obstetric,
behavioural, and potential confounding variables via a stand-
ardised self administered questionnaire at their first MCHC
visit (baseline) and at 3, 9, and 18 months after birth. In par-
ticular, questions ascertaining household smoking habits
included maternal and paternal smoking as well as smoking
by other household members both during pregnancy and after
birth. Utilisation of health services was measured by the
number of physician consultations and episodes of hospitali-
sations since the last MCHC follow up, excluding preventive
visits such as vaccinations and regular well-baby checks.
Mothers were also requested to provide information on the
type of illness (respiratory illness, febrile illness, and other ill-
nesses) leading to the consultation or hospitalisation episode,
the type of clinic or hospital attended (public versus private)
and the associated fees and charges for each episode. Those
respondents who failed to provide some of the detailed data
on type of facility visited or amounts paid for health care did
not differ in the baseline characteristics from those who did
provide complete data; we have therefore assumed that the
corresponding group mean costs also apply to them by
extrapolation. To minimise recall bias, parents were given the
health services utilisation questionnaires to take home and
were asked to fill in the form whenever the infant was taken
for a consultation or was hospitalised. In this way, the
outcomes of interest were documented prospectively and
recorded as they occurred. Using telephone interviewing,
trained research assistants contacted those who could not
complete the questionnaire, and followed up those who did
not return the questionnaire in time to ensure optimal follow
up.
The project received ethics approval from the Ethics
Committee of the Faculty of Medicine, University of Hong
Kong.
Statistical analysis
To determine the risk ratios associated with ETS exposure, we
employed multivariable logistic regression analyses to study
the association between ETS patterns and doctor consulta-
tions and hospitalisations of infant subjects as recorded
during follow up visits at 3, 9, and 18 months of age. Variables
included in the model were selected if they were associated
with a p value <0.05 at bivariable analyses or were included
based on known confounders documented in previous
literature.5–7 The following independent variables were in-
cluded in the final model: breast feeding practice (ever versus
never), birth weight (<2500 g, 2500–2999 g, 3000–3499 g,
3500–3999 g, >4000 g), method of delivery (normal vaginal,
vaginal assisted with suction or forceps, caesarean section),
mother’s age (<24, 25–29, 30–34,>35 years), mother’s educa-
tion level (6th grade or less, 7th to 9th grade, >10th grade),
full time job held by mother (yes or no), and birth order of
infant (first, second, third, or more). The analysis was
restricted to infants who had non-smoking mothers (that is,
never smoking status since pregnancy), as documented in the
baseline survey.
Doctor consultations were dichotomised as either lower or
higher utilisation. Infants were defined as higher “utilisers” of
medical services if they had more consultations than the
median among the sample, adjusted for length of follow up
pro rata. Specifically, we calculated, pro rata, the monthly
number of outpatient visits per month for each infant, then
determined whether use of services was lower or higher than
the median monthly number of consultations in the sample
and dichotomised subjects accordingly. Hospitalisations (that
is, inpatient admissions) were similarly coded. Higher utilisers
of hospital services were in fact those who had ever (one or
more hospitalisation episodes) been admitted. The results of
this part of the analysis have been reported, and the present
study adopted the final adjusted odds ratios (ORs) as the basis
for the main part of the analysis.7
To assess the incremental adverse health impact due to ETS,
taking advantage of the population based design of the study,
we calculated the respective adjusted PARs and their 95% con-
fidence intervals directly from logistic regression for each of
the passive smoking exposure variables.10 This statistical
approach allows for an unbiased estimate of the PAR, even
when the prevalence of the outcome of interest (that is, higher
utiliser in our case) does not satisfy the “rare disease”
assumption, as well as adjusts the estimated effect of one form
of ETS exposure for the effects of others and those of potential
confounders.10 Only those variables that were shown to be sig-
nificantly associated with higher use of health services in the
earlier part of the analysis were included for PAR
calculations.7
For the estimation of additional costs due to ETS exposure
in these infants in terms of an annual birth cohort, we first
worked out the total number of “higher” utilisers for the
population by multiplying the total number of infants born in
Hong Kong in the year 1997 with the prevalence of “higher”
utilisers for the different categories of consultations and hos-
pitalisations. Next, multiplying these estimates of the total
number of “higher” utilisers with the respective differences in
the mean number of episodes between “higher” and “lower”
utilisers (that is, the number of episodes above and beyond
those expected of a “lower” utiliser, since all infants were
expected to generate some health service episodes) per
individual for the various outpatient and inpatient use
categories, the total number of extra episodes generated by the
“higher” utilisers for the different categories were found. Tak-
ing these numbers together with the ETS exposure PARs, we
calculated the number of extra episodes attributable to each
ETS variable. Finally, we estimated the total extra cost attrib-
utable to each ETS variable to be the product of the number of
extra episodes attributable to ETS and the mean associated
cost for the study sample specific for that particular type of
episode. We also calculated the overall relative contribution of
public versus private funding to the total extra costs generated
through the different types of ETS exposure.
The results were standardised pro rata to yearly estimates
and converted to 1997 US dollars (pegged exchange rate US$1
=HK$7.8, £0.61, or &0.85) for easy interpretation. All analyses
were conducted using Stata version 6.0.11
RESULTS
In a previous paper7 we have reported detailed information on
parent-infant characteristics, exposure patterns to tobacco
smoke, and utilisation of health services. Briefly, only 4.6% of
the mothers were ever smokers since conception and were
subsequently excluded from the analysis, while 33.6% of
fathers reported smoking at the baseline MCHC visit. Of the
non-smoking mothers, 50.5% and 14.2% reported occasional
and daily ETS exposure during pregnancy respectively. After
birth, infant exposure to ETS at home from paternal and other
smoking was documented in 41.2% of households. These sta-
tistics are consistent with results from previous surveys of
children and youth in Hong Kong over the past decade.12–14
Table 1 presents the annualised mean,median, 5th and 95th
centile numbers of episodes, in terms of consultations and
hospitalisations, and the associated unit costs for both lower
utilisers and higher utilisers. Higher utilisers attended slightly
more than 10 ambulatory, curative (that is, non-preventive)
visits in the first year of life compared to only three visits for
lower utilisers. Similarly, we observed 1.3 inpatient episodes
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versus none in higher and lower utilisers for any illness. The
mean unit cost for an outpatient appointment was about
US$27 and that for an inpatient episode $1354. These are
broadly in line with corresponding figures from a survey of
medical insurers in Hong Kong for the year 2000,15 where the
average insured individual claimed $31 per outpatient episode
and $1469 for an inpatient visit. These claim figures are about
10–15% higher than our empirical observations, probably
because only about 30% of the local population are covered by
private health insurance and those covered tend to be more
affluent and may seek more expensive care compared to the
general population.16 Inflation, however, should have had little
influence given the Asian financial crisis in the interim. The
relative contributions to the cost of care as shown in table 1 are
also similar to government figures showing that the overall
market share split for ambulatory care between private and
public providers is 85:15 and that for hospitalisation services
8:92.16 Perinatal and paediatric service use might have tilted
towards more private care given the widely perceived conven-
ience and better quality of care by and preference for private
providers among the local population.16
Tables 2 and 3 detail the costs attributable to ETS for asso-
ciations which achieved statistical significance at the 0.05 level
only as previously reported.7 Specifically, table 2 shows the
extra costs incurred as a result of hospitalisation for different
categories of ETS exposure both during and after pregnancy.
For our 1997 annual birth cohort, ETS exposure in utero was
responsible for generating an additional 1581 inpatient
episodes in the first year of life that cost over $2.1 million.
Similarly, postnatal ETS exposure at home from fathers and
other household contacts led to 662 extra hospitalisations
consuming $0.9 million on the population level. There was
also a clear dose-response effect with increasing numbers of
smokers at home (p < 0.05, test for linear trend), in terms of
PAR, extra episodes, and associated costs.
Focusing on the public health and economic impact due to
prenatal ETS exposure via non-smoking mothers, table 3
documents the different utilisation patterns by episode type
and also in terms of type of illness. Such in utero exposure
accounted for $437 000 in outpatient visits alone, where the
majority was due to respiratory or febrile illnesses. A similar
pattern for inpatient visits was also noted.
To put these attributable costs into perspective, we
calculated the total direct medical costs reported for our sam-
ple and projected these for the 1997 annual birth cohort in
Hong Kong for the first year of life to be $39.4 million,
composed of $28.9 million in hospitalisations and $10.5
million in outpatient visits. The corresponding amounts
attributable to ETS exposure in utero and postnatally at home
were $3.04 million in hospital admissions and $0.44 million in
Table 1 Health services utilisation and associated costs in the first year of life for the 1997 birth cohort
Proportion
of higher
utilisers (%)
Annual number of episodes Cost per episode (US$)
Relative contribution
to the cost (%)
Mean
Median
5th
centile
95th
centile Mean Median
5th
centile
95th
centile
Private
sector
Public
sectorOverall
Lower
utiliser
Higher
utiliser
Consultation
Respiratory/fever 46.0 6.7 2.6 8.8 5.0 0 17.0 27 24 13 45 89.2 10.8
Any illness 47.9 8.0 3.0 10.4 7.0 0 21.0 27 24 14 45 87.3 12.7
Hospitalisation
Respiratory/fever 18.1 0.2 0 1.1 0 0 1.0 1253 1142 381 2564 21.1 78.9
Any illness 28.4 0.4 0 1.3 0 0 2.0 1354 1142 381 3045 18.3 81.7
Table 2 Costs of hospitalisation due to any illness in the first year of life attributable to ETS exposure for the 1997
annual birth cohort
Prevalence
(%)
Crude
OR
Adjusted OR* PAR (%)
Extra number of
episodes
attributable to ETS
Total extra
cost
(US$1000)
Relative contribution
to the cost (%)
Point
estimate 95% CI
Point
estimate 95% CI
Private
sector
Public
sector
Exposure to ETS during pregnancy
No 34.9 1 1
Yes 65.1 1.20 1.18 (1.05 to 1.31) 7.4 (2.3 to 12.2) 1581 2142 18.3 81.7
Paternal smoking
No 68.8 1 1
Yes 31.2 1.17 1.08† (0.96 to 1.21) 1.8 (−0.9 to 4.4) N/A N/A N/A N/A
Smoking by others
No 85.8 1 1
Yes 14.2 1.27 1.18‡ (1.01 to 1.37) 1.7 (0.1 to 3.3) 364 492 18.3 81.7
Exposure to ETS at home (by father and others)
No 61.1 1 1
Yes 38.9 1.19 1.12 (1.00 to 1.25) 3.1 (0.0 to 6.2) 662 897 18.3 81.7
Total number of smokers at home
None 61.4 1 1
1 smoker 30.7 1.13 1.07 (0.95 to 1.20) 1.4 (−1.2 to 4.0) N/A N/A N/A N/A
>2 smokers 7.9 1.43 1.30 (1.08 to 1.58) 1.6 (0.4 to 2.8) 342 463 18.3 81.7
OR, odds ratio; CI, confidence interval; PAR, population attributable risk.
N/A denotes items not calculated because the associated PARs did not achieve statistical significance at the 0.05 level.
*Odds ratios are adjusted for maternal education level, maternal full time employment, maternal age, birth order, method of delivery, birth weight, and
breast feeding.
†Additional adjustment for smoking by others.
‡Additional adjustment for paternal smoking.
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outpatient consultations, totalling $3.48 million annually
(that is, 8.8% of total direct medical costs).
DISCUSSION
We found that ETS exposure at any time from the prenatal
period through the first year of life produced substantial mor-
bidity in this Hong Kong Chinese birth cohort that had a sig-
nificant public health impact both in terms of increased health
services use and direct economic costs. By the PAR method, in
utero exposure to ETS through non-smoking mothers
appeared to have imposed a greater population illness burden
than postnatal home smoking by fathers and other household
contacts. Almost 9% of the total direct medical costs in the first
year of life can be attributed to ETS exposure. The representa-
tiveness of the study population base, prospective design, and
high rates of coverage and follow up make it unlikely that the
findings as described are a result of selection or information
bias. We also assessed and controlled for known and potential
confounders by multivariable adjustment procedures. Unlike
previous studies8 17 18 that relied on routine databases and sub-
sequent projections or modelling, our analyses were based on
empirical data collected specifically for the purpose of
addressing our research question. A recent analysis of data19
from the Avon Longitudinal Study of Pregnancy and
Childhood (ALSPAC) also found a similar, independent effect
for in utero tobacco smoke exposure (via smoking mothers) as
well as a dose-response effect for postnatal ETS exposure. The
consistency of evidence, combined with the biological plausi-
bility of our observations as previously discussed,7 lends added
support to the argument that these associations were causal in
nature.
The economic burden estimated in this study is likely a sig-
nificant underestimate of the true cost associated with ETS
exposure to infant health. According to the traditional
taxonomy of economic cost used in the evaluation of health
care interventions, there are three separate categories of costs:
direct, indirect, and intangible.20 Direct costs include medical
care, personal, and other non-health care costs. Direct medical
costs are those incurred by the health care system in the treat-
ment or prevention of the condition. These may include costs
directly related to the interventions for the condition studied,
costs induced as a result of the intervention or information
provided by it, costs required to manage side effects or compli-
cations as a consequence of the intervention, and all
additional health care resources needed to treat conditions
that occur during years of life expectancy added by the inter-
vention. We have included most of these items of direct medi-
cal costs in the study. However, from an economic perspective,
we are interested in assessing all opportunity costs, or what
alternative investments could be made with the same
resources now directed towards health care. The other cost
categories, not having been taken into account in this study,
that make up the total opportunity cost associated with the
effects of ETS exposure on infant health include the following:
(1) Direct personal costs—include transportation expenses to
and from care facilities, costs of providing services in the home
and community, and of support services for recuperation,
rehabilitation, and coping with the disease.
(2) Direct non-health care costs—are those that are not
directly related but attributable to the interventions associated
with the condition, usually borne by other sectors such as
welfare and education.
(3) Indirect costs—include changes in the productive use of
time by patients and others. The twomost important elements
are usually the time costs to patients and caregivers waiting
for treatment or the time spent in hospital, and the productiv-
ity loss in paid and unpaid economic activity due to premature
death or disability. These are especially important in costing
infant health where parents need to accompany the baby for
appointments and inpatient stays as a matter of course com-
pared to other age groups where it is deemed more voluntary
and variable.
(4) Intangible costs of illness—attempt to provide some
measure of the psychological burden and stress on patients,
families, and caregivers, and of any improvements in quality of
life as a result of interventions. These are notoriously difficult
to estimate and are highly controversial as to whether they
should be included in economic assessments.
The annual savings that can potentially materialise from
eliminating household ETS exposure, either through the
smokers quitting or at least smoking outside of the home, are
far greater than the few million dollars of extra health care
cost documented in our results. Other corollary net savings
would include the cost of illness estimates1 for morbidity and
mortality related to other non-smoking household members
such as mothers.21 In addition, should the smokers themselves
decide to quit, the savings from fewer adverse health
outcomes due to active smoking plus those of their coworkers
due to passive smoking would be enormous.
One major methodological limitation of the study bears
mention. We were not able to give a precise estimate of the
total direct medical costs due to the different categories of ETS
exposure, because some of the PARs and therefore associated
costs are not additive. For instance, it would be incorrect to
sum up the costs due to “exposure to ETS during pregnancy”
and “exposure to ETS at home (fathers and others)” in table 2
to give an overall cost attributable to ETS exposure both in
utero and after birth. Although there are epidemiological
methods proposed for evaluating PARs of risk factor
combinations,22 23 they are not applicable here since our expo-
sure variables in the previous example are both related to
Table 3 Costs of health services utilisation in the first year of life attributable to ETS exposure during pregnancy for the
1997 annual birth cohort
Crude
OR
Adjusted OR* PAR (%)
Extra number of
episodes
attributable to ETS
Total extra
cost
(US$1000)
Relative contribution
to the cost (%)
Point
estimate 95% CI
Point
estimate 95% CI
Private
sector
Public
sector
Consultation
Respiratory/fever 1.20 1.19 (1.08 to 1.31) 6.0 (2.6 to 9.4) 10274 273 89.2 10.8
Any illness 1.28 1.26 (1.14 to 1.39) 7.7 (4.3 to 10.9) 16192 437 87.3 12.7
Hospitalisation
Respiratory/fever 1.14 1.11 (0.98 to 1.27) 5.7 (−1.3 to 12.2) N/A N/A N/A N/A
Any illness 1.20 1.18 (1.05 to 1.31) 7.4 (2.3 to 12.2) 1581 2142 18.3 81.7
OR, odds ratio; CI, confidence interval; PAR, population attributable risk.
N/A denotes items not calculated because the associated PARs did not achieve statistical significance at the 0.05 level.
*Odds ratios are adjusted for maternal education level, maternal full time employment, maternal age, birth order, method of delivery, birth weight, and
breast feeding.
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smoking by overlapping groups of smokers albeit at different
time periods. Nonetheless, the ultimate goal of the paper is to
provide scientific evidence necessary for action to reduce the
public health consequences of ETS on paediatric and perinatal
health.
The present data support the revision of public policy to
reflect an evidence based approach to the promotion of smok-
ing cessation in all household members, during as well as after
pregnancy, for reducing the public health and economic
impact due to infant illnesses. The public needs to be made
aware of the costs foregone from exposure to tobacco smoke as
well as the potential savings from a smoke-free society. The
private sector bears a significant proportion of these extra
costs and stands to gain substantially if the exposure is elimi-
nated. On an individual level, the privatisation of these
findings is also important. There should be more effective
health education interventions targeted at family members
who smoke, which not only emphasises the health benefits
from quitting but also the personal economic implications
associated with their smoking in terms of insurance premi-
ums and out of pocket medical expenses.
ACKNOWLEDGEMENTS
This project was funded through a grant from the Hong Kong Health
Care and Promotion Fund (grant no. 216106). We thank the late Dr
Connie O for coordinating the project and all the field work, Professor
AJ Hedley and Dr SM McGhee for their invaluable input in the data
analysis, the Department of Health for their collaboration and
cooperation during data collection, and Marie Chi for expert
secretarial assistance in the preparation of the manuscript.
. . . . . . . . . . . . . . . . . . . . .
Authors’ affiliations
G M Leung, L-M Ho, T-H Lam, Department of Community Medicine,
University of Hong Kong Medical Centre
REFERENCES
1 Tobacco Free Initiative. International consultation on environmental
tobacco smoke (ETS) and child health. Consultation report. Geneva:
World Health Organisation, 1999:12–13.
2 Rose G. The strategy of preventive medicine. Oxford: Oxford University
Press, 1992.
3 Ohara Y, Ohrui T, Morikawa T, et al. Parental attitudes towards passive
smoking Japan [letter]. Lancet 2002;359:1159.
4 Jha P, Chaloupka FJ. The economics of global tobacco control. BMJ
2000;321:358–61.
5 DiFranza JR, Lew RA. Morbidity and mortality in children associated
with the use of tobacco products by other people. Pediatrics
1996;97:560–8.
6 Cook DG, Strachan DP. Summary of effects of parental smoking on the
respiratory health of children and implications for research. Thorax
1999;54:357–66.
7 Lam TH, Leung GM, Ho LM. The effects of environmental tobacco smoke
on health services utilisation in the first eighteen months of life. Pediatrics
2001;107:e91.
8 Stoddard JJ, Gray B. Maternal smoking and medical expenditures for
childhood respiratory illness. Am J Public Health 1997;87:205–9.
9 Department of Health. Annual Report 1997–8. Hong Kong, China:
Government Printers, 1999.
10 Greenland S, Drescher K. Maximum likelihood estimation of the
attributable fraction from logistic models. Biometrics 1993;49:865–72.
11 Stata. Stata reference manual: version 6.0. Santa Monica, CA:
Computing Resource Center, 1992.
12 Hedley AJ, Peters J, Lam TH, et al. Air pollution and respiratory health in
primary school children in Hong Kong, 1989–1992. Report to the
Environmental Protection Department, Hong Kong Government. Hong
Kong: Department of Community Medicine, University of Hong Kong,
1993:330.
13 Lam TH, Chung SF, Wong CM, et al. Youth smoking: knowledge,
attitudes, smoking in schools and families, and symptoms due to passive
smoking. The youth smoking and health survey 1994. Hong Kong: Hong
Kong Council on Smoking and Health, 1995.
14 Lam TH, Hedley AJ, Chung SF, et al. Smoking, passive smoking and
respiratory ill health in primary 3–6 children. Smoking and passive
smoking in children 1998. Hong Kong: Hong Kong Council on Smoking
and Health, 1998.
15 Medical Insurance Association, Hong Kong Federation of Insurers.
Report on the medical fee survey as at 30 June 2000. Hong Kong:
Tillinghast-Towers Perrin, 2001.
16 Hsiao WCL, Yip W, the Harvard Team. Improving Hong Kong’s health
care system: why and for whom? Hong Kong Government Printing
Service, 1999.
17 Oster G, Delea TE, Colditz GA. Maternal smoking during pregnancy
and expenditures on neonatal health care. Am J Prev Med
1988;4:216–19.
18 Miller DP, Villa KF, Hogue SL, et al. Birth and first-year costs for mothers
and infants attributable to maternal smoking. Nicotine Tobacco Research
2001;3:25–35.
19 Lux AL, Henderson AJ, Pocock SJ. Wheeze associated with prenatal
tobacco smoke exposure: a prospective, longitudinal study. Arch Dis
Child 2000;83:307–12.
20 Weinstein MC. Principles of cost-effective resource allocation in health
care organizations. Int J Tech Assess Health Care 1990;6:93–103.
21 Wong CM, Hu ZG, Lam TH, et al. Effects of ambient air pollution and
environmental tobacco smoke on respiratory health of non-smoking
women in Hong Kong. Int J Epidemiol 1999;28:859–64.
22 Bruzzi P, Green SB, Byar DP, et al. Estimating the population attributable
risk for multiple risk factors using case-control data. Am J Epidemiol
1985;122:904–14.
23 Hang M, Hahn RA, Teutsch SM, et al. Multiple risk factors and
population attributable risk for ischemic heart disease mortality in the
United States, 1971–1992. J Clin Epidemiol 2001;54:634–44.
“Oh boy. That habit is gonna cost us . . .” Illustration by Jack Maypole, MD
Economic burden of ETS 771
www.archdischild.com
 on 7 November 2006 adc.bmj.comDownloaded from 
